CYTOO’s breakthrough adhesive micropattern technology for cell assay variability reduction generates significant interest from cell biologists Grenoble, France, September 7, 2009. CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, premiered what it believes is the world’s first and most comprehensive commercially available portfolio of cell adhesive micropattern products […]
Roche, RiNA GmbH, Berlin, and 5 PRIME GmbH, Hamburg agreed that effective September 15, 2009 the complete RTS Protein Expression portfolio of Roche Applied Science will be transferred to RiNA GmbH and 5 PRIME GmbH. RiNA will contribute its longstanding experience in the field of cell-free expression systems and continue production at the same quality […]
Bayer CropScience and Precision BioSciences Inc. Collaborate to Create Site-Specific Genome Modifications in Plants MONHEIM, Germany–Bayer CropScience and Precision BioSciences Inc., a biotechnology company headquartered in Research Triangle Park, NC, USA, announced today that they have entered into a collaborative agreement to create site-specific genome modifications in plants. The agreement provides Bayer CropScience with non-exclusive […]
RICHMOND, Va.–Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market: CBTE) is pleased to announce that it has executed a definitive agreement to acquire all of the outstanding shares of GL Biochem (Shanghai) Ltd, (“GL”) as well as all of the outstanding shares of GL Biochem (Danyang) Ltd, GL Peptide (Binhai) Ltd, and 86% of the shares […]
Enables Breakthrough In Vivo Imaging Analysis of Established Apoptosis and Cell Death Biomarkers in Research and Drug Development BEDFORD, Mass., Sept. 2 — VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Annexin-Vivo 750 imaging agent for measuring and monitoring apoptosis and […]
QIAsafe® DNA Blood Tubes and Plates offer high DNA yield, easy transport and storage at room temperature Venlo, The Netherlands – Biobanks are the intermediary between donors and research labs to ensure the safe effective transfer of the biological information held in samples. The number of biobanks is increasing, as is the cost for power […]
ST. LOUIS and ROMAINVILLE, France, Sept. 1, 2009 — Monsanto Company (NYSE: MON) today announced a non-exclusive research and commercial license agreement with France-based Cellectis S.A. (Alternext: ALCLS), a biotechnology company specialized in genome engineering, for broad use of its meganuclease technology in plants. Meganucleases are molecular scissors that can be directed to a single […]
SANTA CLARA, Calif., Sept. 1 — Cell Biosciences, Inc. today launched a service program to provide phosphoprotein analysis of pre-clinical samples for pharmaceutical and biotechnology companies. Under the Cell Biosciences Focus Assay Service program, client companies receive detailed analytical information about cell signaling proteins in their specimens. This information provides insight into disease processes and […]
Unique U1 adapters silence RNAi refractory genes CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has been awarded $99,750 from the National Institutes of Health ARRA (American Recovery and Reinvestment Act) funding to continue work on its research project ‘Gene Silencing with U1 Adapter Oligonucleotides.’ As a new class of […]
Neihu, Taiwan and Uppsala, Sweden — Olink Bioscience and the Abnova Corporation have signed a distributorship agreement appointing Abnova distributor for the Duolink® in situ PLATM product line in the USA. This agreement is an expansion of a previous co-marketing/co-development agreement under which the companies have been collaborating on the validation of hundreds of target-specific […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
